x

Search for a clinical trial

* (*) mandatory field

245 Result(s)

Sort by

Recruiting trial = Recruiting trial
; Ongoing trial = Ongoing trial
; Funded by an IRDiRC member =

National clinical trial(s)

GERMANY

Baden-Württemberg
ULM

Recruiting trial
Ongoing trial
EMAA: Efficacy and Safety of Eltrombopag in Patients with Acquired Moderate Aplastic Anemia who are treated with Ciclosporin A (Phase II/III) - DE
DRK Baden-Württemberg/ Hessen
Institut für Klinische Transfusionsmedizin und Immungenetik Ulm

GERMANY

Sachsen
DRESDEN

Ongoing trial
A phase III, multicenter, randomised, double-blind, placebo-controlled study of Darbepoetin Alfa for the treatment of anaemic subjects with low or intermediate-1 risk Myelodysplastic Syndrome - DE
Universitätsklinikum Carl Gustav Carus an der TU Dresden
Medizinische Klinik und Poliklinik I - Fachbereich Hämatologie und Blutstammzelltransplantation

AUSTRIA

WIEN
WIEN

Ongoing trial
A Phase 2 Study of LY2784544 in Patients with Myeloproliferative Neoplasms - AT
Allgemeines Krankenhaus der Stadt Wien
Klinische Abteilung für Hämatologie und Hämostaseologie

FRANCE

BRETAGNE
BREST

Thalidomide treatment for agnogenic myeloid metaplasia (Phase II) - Terminated -
CHU de Brest - Hôpital de la Cavale Blanche
Laboratoire d'hématologie

FRANCE

ILE-DE-FRANCE
PARIS

FRANCE

ILE-DE-FRANCE
PARIS

FRANCE

ILE-DE-FRANCE
PARIS

VPACS : Non Invasive Positive Pressure Ventilation for Prevention of Acute Chest Syndrome in Sickle Cell Disease With Vaso-occlusive Crisis and Morphinic Treatment
Hôpital Necker-Enfants Malades
Service de Réanimation et unités de soins continus médico-chirurgicale pédiatriques

FRANCE

OUTRE-MER
FORT DE FRANCE

Efficacy and Safety of Bosentan in Sickle Cell Disease (SCD) Patients With Pulmonary Arterial Hypertension (PAH) (Phase III)
CHU de Martinique - Hôpital P. Zobda-Quitman
Cardiologie Pédiatrique et Congénitale

GERMANY

Baden-Württemberg
HEIDELBERG

Ongoing trial
MPN-SG 01-09 (MPN Pomalidomide): Multicenter Phase II Study with Pomalidomide in patients with Myeloproliferative Neoplasms in fibrotic Stage
Nationales Centrum für Tumorerkrankungen (NCT)
Nationales Centrum für Tumorerkrankungen (CCC) Heidelberg

GERMANY

Baden-Württemberg
ULM

GERMANY

Hamburg
HAMBURG

Recruiting trial
Ongoing trial
Ruxolitinib versus allogeneic stem cell transplantation for patients with myelofibrosis according to donor availability: A prospective phase II trial (MMM 02 study) - DE
UKE - Universitätsklinikum Hamburg-Eppendorf
Interdisziplinäre Klinik und Poliklinik für Stammzelltransplantation

GERMANY

Nordrhein-Westfalen
AACHEN

GERMANY

Nordrhein-Westfalen
MINDEN

Ongoing trial
JHTB(a): A Phase 2 Study of LY2784544 in Patients With Myeloproliferative Neoplasms - DE
Johannes Wesling Klinikum Minden
Klinik für Hämatologie, Onkologie und Palliativmedizin

NETHERLANDS

Gelderland
NIJMEGEN

NETHERLANDS

Noord-Holland
AMSTERDAM

NETHERLANDS

Noord-Holland
AMSTERDAM

Ongoing trial
Microvascular Damage in Sickle Cell Disease
Amsterdam UMC, locatie AMC
Afdeling Hematologie

SPAIN

Madrid
ADDRESS: NOT PROVIDED - ES

UNITED KINGDOM

Greater London
LONDON

UNITED KINGDOM

Greater Manchester
ADDRESS: NOT PROVIDED - UK

UNITED KINGDOM

Greater Manchester
ADDRESS: NOT PROVIDED - UK

UNITED KINGDOM

West Midlands
BIRMINGHAM

UNITED STATES

Ohio
CINCINNATI

Recruiting trial
Ongoing trial
Funded by an IRDiRC memberQuercetin in Children With Fanconi Anemia; a Pilot Study (Phase 1) - US
Cincinnati Children's Hospital Medical Center
Department of Pediatry

AUSTRIA

WIEN
ADDRESS: NOT PROVIDED - AT

FRANCE

NOUVELLE AQUITAINE
PESSAC

ANEMIL : Phase I/II Clinical Trial Evaluating the Interest of Interleukine-2 for Patients With Active Warm Hemolytic Anemia Resistant to Conventional Treatment
CHU de Bordeaux-GH Sud - Hôpital Haut-Lévêque
Service de médecine interne et maladies infectieuses (Sud)

GERMANY

Baden-Württemberg
HEIDELBERG

An open-label, multicentre controlled clinical trial of Eculizumab in adult patients with plasma therapy-resistant Atypical Hemolytic-Uremic Syndrome (aHUS) (Phase II) - DE
Zentrum für Kinder- und Jugendmedizin - Angelika-Lautenschläger-Klinik
Klinik für Kinderheilkunde I - Sektion Pädiatrische Nephrologie

GERMANY

Baden-Württemberg
HEIDELBERG

An open-label, multicentre controlled clinical trial of Eculizumab in adult patients with plasma therapy-sensitive Atypical Hemolytic-Uremic Syndrome (aHUS) (Phase II) - DE
Zentrum für Kinder- und Jugendmedizin - Angelika-Lautenschläger-Klinik
Klinik für Kinderheilkunde I - Sektion Pädiatrische Nephrologie

GERMANY

Baden-Württemberg
HEIDELBERG

An open-label, multicentre clinical trial of Eculizumab in pediatric patients with Atypical Hemolytic-Uremic Syndrome (aHUS) (Phase II) - DE- Completed
Zentrum für Kinder- und Jugendmedizin - Angelika-Lautenschläger-Klinik
Klinik für Kinderheilkunde I - Sektion Pädiatrische Nephrologie

ITALY

EMILIA ROMAGNA
FERRARA

Ongoing trial
An Open-Label Extension Study to Evaluate the Long-Term Effects of ACE-536 in Patients With beta-Thalassemia Previously Enrolled in Study A536-04
A.O.U. di Ferrara - Nuovo Ospedale S.Anna - Sede di Cona
Day Hospital della Talassemia e delle Emoglobinopatie

ITALY

LAZIO
ROMA

Phase 2, Double-Blind, Placebo Controlled Clinical Trial of EPI-743 in Subjects With Cobalamin C Defect
IRCCS Ospedale Pediatrico Bambino Gesù - SEDE SAN PAOLO
U.O.C. di Patologia Metabolica

ITALY

LOMBARDIA
MILANO

Recruiting trial
Ongoing trial
An open-label, multi-center clinical trial of eculizumab in pediatric patients with atypical hemolytic-uremic syndrome (aHUS) (Phase II) - IT
IRCCS Ca' Granda - Ospedale Maggiore Policlinico - Clinica Pediatrica De Marchi
Centro per la Cura e lo Studio della Sindrome Emolitico Uremica (Center for HUS Control)

ITALY

LOMBARDIA
PAVIA

Eltrombopag per le trombocitopenie ereditarie
Fondazione IRCCS Policlinico San Matteo
Clinica Medica III

NETHERLANDS

Gelderland
NIJMEGEN

SPAIN

Cataluña
BARCELONA

UNITED KINGDOM

Greater London
LONDON

Ongoing trial
An open-label, multi-center clinical trial of eculizumab in pediatric patients with atypical hemolytic-uremic syndrome (aHUS) (Phase II) - UK
University College London Hospitals, NHS Foundation Trust
Renal Office - Consultant Paediatric Nephrologist

UNITED KINGDOM

Tyne & Wear
NEWCASTLE UPON TYNE

An open-label, multi-center controlled clinical trial of eculizumab in adult patients with plasma therapy-resistant Atypical Hemolytic-Uremic Syndrome (aHUS) (Phase II) - UK -
Newcastle upon Tyne Hospitals NHS Trust
John Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine

UNITED KINGDOM

Tyne & Wear
NEWCASTLE UPON TYNE

An open-label, multi-center controlled clinical trial of eculizumab in adolescent patients with plasma therapy-resistant Atypical Hemolytic-Uremic Syndrome (aHUS) (Phase II) - UK -
Newcastle upon Tyne Hospitals NHS Trust
John Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine

UNITED KINGDOM

Tyne & Wear
NEWCASTLE UPON TYNE

An open-label, multi-center controlled clinical trial of eculizumab in adult patients with plasma therapy-sensitive Atypical Hemolytic-Uremic Syndrome (aHUS) (Phase II) - UK
Newcastle upon Tyne Hospitals NHS Trust
John Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine

UNITED KINGDOM

Tyne & Wear
NEWCASTLE UPON TYNE

An open-label, multi-center controlled clinical trial of eculizumab in adolescent patients with plasma therapy-sensitive Atypical Hemolytic-Uremic Syndrome (aHUS) (Phase II) - UK
Newcastle upon Tyne Hospitals NHS Trust
John Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine

ITALY

LOMBARDIA
BRESCIA

Multinational clinical trial(s)

SPAIN

Madrid
MADRID

Ongoing trial
Funded by an IRDiRC memberEUROFANCOLEN: Phase I/II Gene Therapy Trial of Fanconi anemia patients with a new Orphan Drug consisting of a lentiviral vector carrying the FANCA gene: A Coordinated International Action
CIEMAT - Centro de Investigaciones Energéticas Medioambientales y Tecnológicas
Terapias innovadoras en el sistema hematopoyético